Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for disinfecting surfaces and hands; and veterinary medicines. Its products are available in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, pessaries, and suppositories. It offers active pharmaceutical ingredients. The company exports its products to approximately 70 countries. Antibiotice S.A. was founded in 1955 and is headquartered in Iasi, Romania.
Frequently asked questions
What sector does Antibiotice Ia (ATB) operate in?
Antibiotice Ia belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Antibiotice Ia (ATB) current stock price?
As of the latest data, Antibiotice Ia stock price is RON 2.14, with a previous close of RON 2.14. Antibiotice Ia lost -RON 0.01 in the last trading session, representing a -0.23% loss.
What is Antibiotice Ia (ATB) current market capitalization?
Antibiotice Ia market cap is approximately 1.43 billion.
What is Antibiotice Ia (ATB) Earnings Per Share (EPS)?
The trailing EPS is RON 0.05.
What is Antibiotice Ia (ATB) Price-to-Earnings (P/E) ratio?
Antibiotice Ia current P/E ratio is 42.7.
Does Antibiotice Ia (ATB) pay dividends?
Yes. Antibiotice Ia pays annual dividends with an annualized yield of 0.96% and an estimated annual payout of RON 0.02 per share.
When is the next ex-dividend date for Antibiotice Ia (ATB)?
The next ex-dividend date is scheduled for September 25, 2026.
What is Antibiotice Ia (ATB) beta (volatility) score?
Antibiotice Ia has a beta of 0.229, indicating lower volatility than the overall market.
